Discovery and exploration of novel somatostatin receptor subtype 5 (SSTR5) antagonists for the treatment of cholesterol gallstones
- 5 December 2023
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 264, 116017
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82121005, 82273764)
- State Key Laboratory of Drug Research, Chinese Academy of Sciences
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
This publication has 28 references indexed in Scilit:
- Piperidinyl-nicotinamides as potent and selective somatostatin receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2010
- Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in miceNeurogastroenterology & Motility, 2010
- Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonistsBioorganic & Medicinal Chemistry Letters, 2009
- Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and PancreasGastroenterology, 2009
- Roles of Infection, Inflammation, and the Immune System in Cholesterol Gallstone FormationGastroenterology, 2009
- Coordinate regulation of gallbladder motor function in the gut-liver axisHepatology, 2008
- Discovery of the First Nonpeptidic, Small-Molecule, Highly Selective Somatostatin Receptor Subtype 5 Antagonists: A Chemogenomics ApproachJournal of Medicinal Chemistry, 2007
- Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstonesGastroenterology, 1995
- Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammationJournal of Hepatology, 1994
- Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjectsJournal of Hepatology, 1992